VEEV
Veeva Systems Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$275.06
−3.28%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
28.5x
EV/EBITDA
27.3x
Market Cap
$44.53B
MomentumView details →
1D Return
−3.28%
YTD Return
+23.00%
RSI (14)
65.5
ValuationView details →
P/E (Fwd)
28.5x
EV/EBITDA
27.3x
Market Cap
$44.53B
RSI (14)
65.5
MomentumView details →
1D Return
−3.28%
YTD Return
+23.00%
SummaryUpdated Jul 1, 2026
Veeva Systems Inc. (NYSE:VEEV) is a leading provider of cloud-based software solutions specifically designed for the global life sciences industry. Founded in 2007 and headquartered in Pleasanton, California, the company went public in 2013 and has established itself as the dominant technology platform serving pharmaceutical, biotechnology, and medical device companies worldwide. Veeva operates as a specialized software-as-a-service (SaaS) provider, focusing exclusively on the unique regulatory, compliance, and operational needs of life sciences organizations throughout their drug development and commercialization processes.
Similar companies
Latest newsMore news →
Michael Burry reduced his stake in Veeva Systems after the stock's recent rally, while reiterating his bullish stance.12h agoVeeva Systems announced the launch of Veeva Falcon Safety, an agentic safety operations product for biopharma companies to streamline adverse event intake, case processing, and follow-up.3d ago